SCHEMBL4773162

SCHEMBL4773162

COc1cccc2c(CCNc3cc(-c4cccnc4)nc(-c4ccccn4)n3)c[nH]c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 10/20 0.51
CYP3A4 P08684 10/20 0.51
CYP2D6 P10635 10/20 0.51
CYP2C19 P33261 10/20 0.51
CLK4 Q9HAZ1 10/20 0.51
USP2 O75604 8/20 0.51
HSD17B10 Q99714 6/20 0.51
CYP2C9 P11712 5/20 0.51
ALOX15 P16050 5/20 0.51
ALDH1A1 P00352 4/20 0.51
TSHR P16473 4/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
LMNA P02545 3/20 0.47
MTNR1A P48039 1/20 0.45
MTNR1B P49286 1/20 0.45
PTGDR Q13258 4/20 0.45
GBA1 P04062 1/20 0.43
CDK4 P11802 1/20 0.43
CCND1 P24385 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2239349 0.89 CDK4 (0.47) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL2241872 0.88 CDK4 (0.50) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL2239531 0.87 CDK4 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL3962080 0.84 CDK4 (0.58) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL2237989 0.84 CYP1A2 (0.63) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL2241071 0.81 CYP3A4 (0.57) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL2237840 0.81 CYP1A2 (0.49) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL2245206 0.81 CYP1A2 (0.55) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL2241055 0.81 CYP3A4 (0.51) CYP1A2CYP3A4CYP2D6CYP2C19CLK4
SCHEMBL2238664 0.79 CYP3A4 (0.47) CYP1A2CYP3A4CYP2D6CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed